These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 21557880)

  • 1. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults.
    Cohen M; Rasser PE; Peck G; Carr VJ; Ward PB; Thompson PM; Johnston P; Baker A; Schall U
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):297-307. PubMed ID: 21557880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar white-matter changes in cannabis users with and without schizophrenia.
    Solowij N; Yücel M; Respondek C; Whittle S; Lindsay E; Pantelis C; Lubman DI
    Psychol Med; 2011 Nov; 41(11):2349-59. PubMed ID: 21466751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebellar grey matter deficits in first-episode schizophrenia mapped using cortical pattern matching.
    Rasser PE; Schall U; Peck G; Cohen M; Johnston P; Khoo K; Carr VJ; Ward PB; Thompson PM
    Neuroimage; 2010 Dec; 53(4):1175-80. PubMed ID: 20633666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Rais M; van Haren NE; Cahn W; Schnack HG; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS
    Eur Neuropsychopharmacol; 2010 Dec; 20(12):855-65. PubMed ID: 20863671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia.
    Szeszko PR; Robinson DG; Sevy S; Kumra S; Rupp CI; Betensky JD; Lencz T; Ashtari M; Kane JM; Malhotra AK; Gunduz-Bruce H; Napolitano B; Bilder RM
    Br J Psychiatry; 2007 Mar; 190():230-6. PubMed ID: 17329743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter morphological anomalies in the cerebellar vermis in first-episode schizophrenia patients with cognitive deficits.
    Wang J; Zhou L; Cui C; Liu Z; Lu J
    BMC Psychiatry; 2017 Nov; 17(1):374. PubMed ID: 29166884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls.
    Cousijn J; Wiers RW; Ridderinkhof KR; van den Brink W; Veltman DJ; Goudriaan AE
    Neuroimage; 2012 Feb; 59(4):3845-51. PubMed ID: 21982932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar deficits in schizophrenia are associated with executive dysfunction.
    Segarra N; Bernardo M; Valdes M; Caldu X; Falcón C; Rami L; Bargallo N; Parramon G; Junque C
    Neuroreport; 2008 Oct; 19(15):1513-7. PubMed ID: 18797308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.
    Koenders L; Machielsen MW; van der Meer FJ; van Gasselt AC; Meijer CJ; van den Brink W; Koeter MW; Caan MW; Cousijn J; den Braber A; van 't Ent D; Rive MM; Schene AH; van de Giessen E; Huyser C; de Kwaasteniet BP; Veltman DJ; de Haan L
    J Psychiatry Neurosci; 2015 May; 40(3):197-206. PubMed ID: 25510948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients.
    Rais M; Cahn W; Van Haren N; Schnack H; Caspers E; Hulshoff Pol H; Kahn R
    Am J Psychiatry; 2008 Apr; 165(4):490-6. PubMed ID: 18281413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cortical maturation in adolescent cannabis users with and without schizophrenia.
    Epstein KA; Kumra S
    Schizophr Res; 2015 Mar; 162(1-3):143-52. PubMed ID: 25600549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise study.
    Tordesillas-Gutierrez D; Koutsouleris N; Roiz-Santiañez R; Meisenzahl E; Ayesa-Arriola R; Marco de Lucas E; Soriano-Mas C; Suarez-Pinilla P; Crespo-Facorro B
    Schizophr Res; 2015 May; 164(1-3):74-82. PubMed ID: 25687531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use and brain structural alterations of the cingulate cortex in early psychosis.
    Rapp C; Walter A; Studerus E; Bugra H; Tamagni C; Röthlisberger M; Borgwardt S; Aston J; Riecher-Rössler A
    Psychiatry Res; 2013 Nov; 214(2):102-8. PubMed ID: 24054726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebellar vermis white-matter volume in men with schizophrenia.
    Lee KH; Farrow TF; Parks RW; Newton LD; Mir NU; Egleston PN; Brown WH; Wilkinson ID; Woodruff PW
    J Psychiatr Res; 2007 Oct; 41(8):645-51. PubMed ID: 16626741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia.
    Sullivan EV; Deshmukh A; Desmond JE; Mathalon DH; Rosenbloom MJ; Lim KO; Pfefferbaum A
    Arch Gen Psychiatry; 2000 Sep; 57(9):894-902. PubMed ID: 10986553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume.
    Wetherill RR; Jagannathan K; Hager N; Childress AR; Rao H; Franklin TR
    Int J Neuropsychopharmacol; 2015 Jun; 18(10):pyv061. PubMed ID: 26045474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine use severity and cerebellar gray matter are associated with reversal learning deficits in cocaine-dependent individuals.
    Moreno-López L; Perales JC; van Son D; Albein-Urios N; Soriano-Mas C; Martinez-Gonzalez JM; Wiers RW; Verdejo-García A
    Addict Biol; 2015 May; 20(3):546-56. PubMed ID: 24738841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural neuroimaging correlates of alcohol and cannabis use in adolescents and adults.
    Thayer RE; YorkWilliams S; Karoly HC; Sabbineni A; Ewing SF; Bryan AD; Hutchison KE
    Addiction; 2017 Dec; 112(12):2144-2154. PubMed ID: 28646566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalamic and Cerebellar Gray Matter Volume Reduction in Synthetic Cannabinoids Users.
    Nurmedov S; Metin B; Ekmen S; Noyan O; Yilmaz O; Darcin A; Dilbaz N
    Eur Addict Res; 2015; 21(6):315-20. PubMed ID: 26021304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia.
    Zhang C; Wang Q; Ni P; Deng W; Li Y; Zhao L; Ma X; Wang Y; Yu H; Li X; Zhang P; Meng Y; Liang S; Li M; Li T
    Sci Rep; 2017 Aug; 7(1):10267. PubMed ID: 28860557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.